JPWO2023193003A5 - - Google Patents
Info
- Publication number
- JPWO2023193003A5 JPWO2023193003A5 JP2024557470A JP2024557470A JPWO2023193003A5 JP WO2023193003 A5 JPWO2023193003 A5 JP WO2023193003A5 JP 2024557470 A JP2024557470 A JP 2024557470A JP 2024557470 A JP2024557470 A JP 2024557470A JP WO2023193003 A5 JPWO2023193003 A5 JP WO2023193003A5
- Authority
- JP
- Japan
- Prior art keywords
- individually
- sequence numbers
- numbers
- individually sequence
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263326269P | 2022-03-31 | 2022-03-31 | |
| US63/326,269 | 2022-03-31 | ||
| US202263341681P | 2022-05-13 | 2022-05-13 | |
| US63/341,681 | 2022-05-13 | ||
| PCT/US2023/065233 WO2023193003A2 (en) | 2022-03-31 | 2023-03-31 | Cd4-specific antibody constructs and compositions and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025510948A JP2025510948A (ja) | 2025-04-15 |
| JP2025510948A5 JP2025510948A5 (https=) | 2026-04-08 |
| JPWO2023193003A5 true JPWO2023193003A5 (https=) | 2026-04-08 |
Family
ID=88203505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557470A Pending JP2025510948A (ja) | 2022-03-31 | 2023-03-31 | Ｃｄ４特異的抗体構築物及び組成物ならびにその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250281536A1 (https=) |
| EP (1) | EP4499706A2 (https=) |
| JP (1) | JP2025510948A (https=) |
| KR (1) | KR20250005572A (https=) |
| CN (1) | CN119317642A (https=) |
| AU (1) | AU2023243626A1 (https=) |
| CA (1) | CA3255336A1 (https=) |
| IL (1) | IL315572A (https=) |
| WO (1) | WO2023193003A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20260098062A1 (en) * | 2022-09-21 | 2026-04-09 | Sana Biotechnology, Inc. | Lipid particles comprising variant paramyxovirus attachment glycoproteins and uses thereof |
| CN118146376B (zh) * | 2024-05-09 | 2024-07-05 | 成都微芯新域生物技术有限公司 | Hla-g抗体及其制备方法和用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2352764B1 (en) * | 2008-10-14 | 2018-03-28 | Ablynx N.V. | AMINO ACID SEQUENCES TARGETING HUMAN CD4 and CXCR4, CCR5, TLR4, ALPHAV INTEGRIN, BETA3-INTEGRIN,BETA1-INTEGRIN, HUMAN ALPHA2-INTEGRIN, CD81, SR-BI, CLAUDIN-1, CLAUDIN-6 AND/OR CLAUDIN-9, RESPECTIVELY, AND NEUTRALIZING VIRAL ENTRY |
| EP3448987A4 (en) * | 2016-04-29 | 2020-05-27 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| CA3091478A1 (en) * | 2018-02-17 | 2019-08-22 | Flagship Pioneering Innovations V, Inc. | Compositions and methods for membrane protein delivery |
| US12139534B2 (en) * | 2018-03-15 | 2024-11-12 | Biond Biologics Ltd. | Methods and compositions for decreasing soluble immune receptor CD28 |
| WO2020010235A1 (en) * | 2018-07-05 | 2020-01-09 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Car t cells that target b-cell antigens |
| WO2023015217A1 (en) * | 2021-08-04 | 2023-02-09 | Sana Biotechnology, Inc. | Use of cd4-targeted viral vectors |
-
2023
- 2023-03-31 US US18/852,220 patent/US20250281536A1/en active Pending
- 2023-03-31 WO PCT/US2023/065233 patent/WO2023193003A2/en not_active Ceased
- 2023-03-31 EP EP23782106.1A patent/EP4499706A2/en active Pending
- 2023-03-31 AU AU2023243626A patent/AU2023243626A1/en active Pending
- 2023-03-31 KR KR1020247035855A patent/KR20250005572A/ko active Pending
- 2023-03-31 IL IL315572A patent/IL315572A/en unknown
- 2023-03-31 CN CN202380043231.8A patent/CN119317642A/zh active Pending
- 2023-03-31 CA CA3255336A patent/CA3255336A1/en active Pending
- 2023-03-31 JP JP2024557470A patent/JP2025510948A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018241252B2 (en) | Chimeric molecules and uses thereof | |
| JP2023060000A (ja) | レトロウイルスおよびレンチウイルスベクター | |
| JP7669327B2 (ja) | ナチュラルキラー細胞免疫療法における切断されたｎｋｇ２ｄキメラ受容体及びその使用 | |
| US11591613B2 (en) | Retroviral and lentiviral vectors | |
| US11414491B2 (en) | Targeting PD-L1 on tumor cells | |
| JPWO2022216915A5 (https=) | ||
| JP2008541768A (ja) | ウィルスベクターを使用した標的化遺伝子送達方法 | |
| JP2022513326A5 (https=) | ||
| KR20240013173A (ko) | Nkg2d-기초 키메라 항원 수용체 | |
| CN120936364A (zh) | 修饰的弹状病毒糖蛋白及其用途 | |
| KR20240019811A (ko) | Gpc3 결합 분자 | |
| JPWO2023193003A5 (https=) | ||
| CN120302988A (zh) | 新型抗间皮素嵌合抗原受体和经修饰的免疫细胞 | |
| CA3255336A1 (en) | CD4-SPECIFIC ANTIBODY CONSTRUCTIONS AND ASSOCIATED COMPOSITIONS AND USES | |
| JP2021529539A5 (https=) | ||
| CN106467576A (zh) | 一种抗体融合蛋白及其制备方法与应用 | |
| CA3230810A1 (en) | Gene sequence construct for gene therapy of human immunodeficiency virus infection | |
| WO2023030312A1 (zh) | 一种用于艾滋病病毒感染基因治疗的基因序列构建体 | |
| Chiyyeadu | Antibody-based strategies for infectious diseases, regenerative medicine and cancer | |
| JP2025539364A (ja) | 遺伝子操作ｔ細胞 | |
| KR20250060244A (ko) | 조작된 외피보유 벡터 및 이의 사용 방법 |